LOGO 2120 (Valproic Acid 250 mg)
Pill with imprint LOGO 2120 is White, Capsule-shape and has been identified as Valproic Acid 250 mg. It is supplied by United Research Laboratories/Mutual Pharmaceutical Company.
Valproic acid is used in the treatment of epilepsy; bipolar disorder; mania; seizure prevention; schizoaffective disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LOGO 2120
Valproic Acid
- Imprint:
- LOGO 2120
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine - CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- United Research Laboratories/Mutual Pharmaceutical Company
- National Drug Code (NDC):
- 00677-1079
More about valproic acid
- Valproic acid Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 30 Reviews
- Drug class: fatty acid derivative anticonvulsants
Consumer resources
- Valproic acid
- Valproate Injection
- Valproic Acid Capsules
- Valproic Acid Delayed-Release Capsules
- Valproic Acid Liquid
- Valproic acid (Advanced Reading)
Other brands: Valproate Sodium, Depakene, Depacon, Stavzor
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
